Profile
Jelix Ventures is an early-stage venture capital firm based in Australia, focusing on supporting daring founders across Australia and New Zealand. Founded by experienced professionals with a passion for innovation, Jelix offers a dynamic team committed to empowering startups to build a better future. The firm differentiates itself through deep engagement with portfolio companies and a personalized approach to investing.
Jelix Ventures invests primarily in early-stage companies, with specific interest in AI, biotechnology, and health tech sectors. They provide a range of funding options suitable for pre-seed, seed, and series A rounds, focusing on startups within the Oceania region. Jelix aims to drive meaningful impact across its portfolio, leveraging its network and insights to guide emerging companies.
Notable investments include PropHero, an AI-powered property investment platform; Gelomics, focusing on 3D cell cultures; and Syenta, involved in tech innovations. Jelix is recognized for a strong commitment to backing impactful technologies that align with their investment thesis.
Industry
Jelix Ventures Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Jelix Ventures Innovation (Fund1)
|
Venture Capital (VC)
|
AI
Healthcare Services
Financial Services
Business Services (B2B)
Biotechnology
HealthTech
|
Pre-seed
Seed
Series A
|
Australia and others
|
$1-5 m
|
—
|
January 2021
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.